Indo Rama Board Approves FY26 Audited Results; Appoints Auditors, Sets AGM Date
Indo Rama's Board approved FY26 audited standalone and consolidated results. Deloitte Haskins & Sells LLP appointed internal auditors, and R. Krishnan re-appointed cost auditor for FY27. No dividend declared for FY26. The 40th AGM is on September 8, 2026.
The approval of financial results, auditor appointments, and AGM date are standard corporate governance activities. The inability to declare a dividend and the changes in financial performance metrics might have a moderate impact on investor perception.
The announcement reports on routine corporate actions like financial results approval and auditor appointments. While the results are approved, the inability to declare a dividend and the decrease in cash flow from operations for the year point to a neutral sentiment.
Indo Rama Synthetics (India) Limited announced the outcome of its Board Meeting held on May 25, 2026. The Board approved the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026. Unmodified audit reports were received for these results. The company also approved the publication of extracts of the audited financial results and will post them on its website. M/s Deloitte Haskins & Sells LLP has been appointed as the Internal Auditors for the financial year 2026-27, and Mr. R. Krishnan has been re-appointed as the Cost Auditor for the same period. The company is unable to declare a dividend for FY 2025-26. The 40th Annual General Meeting (AGM) is scheduled for Tuesday, September 8, 2026, to be conducted via Video Conferencing/OAVM facility.
The Board Meeting commenced at 12:00 PM IST and concluded at 5:30 PM IST. The audited standalone financial statements show total assets of ₹3,091.08 crore as of March 31, 2026, compared to ₹2,664.10 crore in the previous year. Total equity stands at ₹563.76 crore, up from ₹452.96 crore. Non-current liabilities increased to ₹407.71 crore from ₹226.08 crore, while current liabilities rose to ₹2,222.84 crore from ₹1,153.30 crore. The standalone cash flow from operations for the year ended March 31, 2026, was ₹45.87 crore, a significant decrease from ₹335.86 crore in the prior year. Investing activities used ₹25.04 crore, and financing activities generated ₹129.30 crore. The consolidated financial statements indicate total assets of ₹3,244.09 crore as of March 31, 2026, compared to ₹2,935.66 crore in the previous year. Total equity increased to ₹519.47 crore from ₹368.21 crore. Non-current liabilities rose to ₹502.08 crore from ₹414.45 crore, and current liabilities increased to ₹2,222.84 crore from ₹1,153.30 crore. The consolidated cash flow from operations for the year ended March 31, 2026, was ₹150.21 crore, a decrease from ₹190.55 crore in the prior year. Investing activities used ₹25.04 crore, and financing activities used ₹129.30 crore.
What to do with a filing like this
Indo Rama Synthetics (India) Limited filed this with the NSE as a statutory disclosure, categorised under other results related. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indo Rama Synthetics (India) Limited. Read the original for the full detail.